JMP Securities analyst Daniel Stauder has reiterated their neutral stance on AVNS stock, giving a Hold rating yesterday. Daniel ...

In the third quarter of 2024, Avanos Medical reported sales of $170 million, representing a 1% year-over-year decline and falling short of expectations by approximately $5 million. This ...

Q3 2024 Earnings Call Transcript October 30, 2024 Avanos Medical, Inc. misses on earnings expectations. Reported EPS is $ EPS ...

In other recent news, Avanos Medical has reported a 2.6% increase in sales from continuing operations, totaling $172 million in the second quarter of 2024. The company's Digestive Health portfolio ...

The company generated approximately $170 million of sales from continuing operations and $31 million of adjusted EBITDA, indicating strong financial performance. Avanos Medical Inc (NYSE ...

Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago. These figures are ...

The medical technology company posted revenue of $170.4 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $175 million. Avanos Medical expects full-year ...

ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Avanos Medical, Inc. (AVNS) on Wednesday reported third-quarter net income of $4.3 million, after reporting a loss in the same period a year earlier.